Cancer BiologyCellular & Molecular Biology LettersPeer-reviewed
BRD2 Upregulation as a Pan-Cancer Adaptive Resistance Mechanism to BET Inhibition
Suyakarn Archasappawat, Juliette Jacques, Eunjung Lee, Chang‐Il Hwang
This study identifies BRD2 upregulation as a common adaptive resistance mechanism to BET inhibitors across cancers and shows that targeting BRD2 or NFYA can enhance BET inhibitor efficacy.